Similar articles

• The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.

  Morley CJ. Morley CJ. Eur Respir J Suppl. 1989 Mar;3:81s-86s. Eur Respir J Suppl. 1989. PMID: 2663001 Clinical Trial.
• The development of surfactant replacement therapy and the various types of replacement surfactants.

  Shapiro DL. Shapiro DL. Semin Perinatol. 1988 Jul;12(3):174-9. Semin Perinatol. 1988. PMID: 3041602 Review.
• Artificial reconstituted pulmonary surfactant in prevention and treatment of respiratory distress syndrome in neonates.

  Jiang ZQ, Sun GM, Ma YM. Jiang ZQ, et al. Zhongguo Yao Li Xue Bao. 1997 Mar;18(2):182-4. Zhongguo Yao Li Xue Bao. 1997. PMID: 10072978
• Use of natural surfactants to prevent and treat respiratory distress syndrome.

  Spafford PS, Kendig JW, Maniscalco WM. Spafford PS, et al. Semin Perinatol. 1993 Aug;17(4):285-94. Semin Perinatol. 1993. PMID: 8140443 Review. No abstract available.
• [Surfactant supplement therapy for neonatal respiratory distress syndrome (author's transl)].

  Kobayashi T, Murakami S, Haruki S, Oda T. Kobayashi T, et al. Kokyu To Junkan. 1982 Jun;30(6):589-94. Kokyu To Junkan. 1982. PMID: 6896761 Japanese. No abstract available.